NCT06247150View on ClinicalTrials.gov

Tissue Immune Landscape of Graft Versus Host Disease After Allogeneic Stem Cell Transplantation (TIL-GVHD)

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

May 21, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

June 30, 2026

Conditions
Chronic Graft Versus Host Disease
Interventions
BIOLOGICAL

Additional blood sample

The procedure will consist of an additional blood sample for 3 ETDA tubes collection (NGS analysis) and citrate tube collection (NETose analysis)

BIOLOGICAL

cGVHD target tissue biopsy

For chronic GVH patients only, cGVHD target tissue biopsy

Trial Locations (1)

Unknown

RECRUITING

CHU de Bordeaux, Service d'Hématologie Clinique et Thérapie Cellulaire, Pessac

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER